Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Coh...

por Griffiths, Robert I., Gleeson, Michelle L., Mikhael, Joseph, Danese, Mark D.
Publicado 2012

Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare

por Griffiths, Robert I, Danese, Mark D, Gleeson, Michelle L, Valderas, José M
Publicado 2012

Impact of Undetected Comorbidity on Treatment and Outcomes of Breast Cancer

por Griffiths, Robert I., Gleeson, Michelle L., Valderas, José M., Danese, Mark D.
Publicado 2014

Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data

por Danese, Mark D., Reyes, Carolina M., Gleeson, Michelle L., Halperin, Marc, Skettino, Sandra L., Mikhael, Joseph
Publicado 2016

Undiagnosed Diabetes in Breast, Colorectal, Lung, and Prostate Cancer: Incidence and Risk Factors

por Griffiths, Robert I., Lindquist, Karla J., O'Malley, Cynthia D., Gleeson, Michelle L., Duryea, Jennifer L., Valderas, José M., Danese, Mark D.
Publicado 2014